Abstract:The challenge of methotrexate (MTX) resistance among low-risk gestational trophoblastic neoplasia (GTN) patients has always been prominent. Despite the International Federation of Gynaecology and Obstetrics (FIGO) score of 0-4 patients comprising the majority of low-risk GTN patients, a comprehensive exploration of the prevalence and risk factors associated with MTX resistance has been limited. Therefore, we aimed to identify associated risk factors in GTN patients with a FIGO score of 0-4. Between January 2005 and December 2020, 310 low-risk GTN patients received primary MTX chemotherapy in two hospitals, with 265 having a FIGO score of 0-4. In the FIGO 0-4 subgroup, 94 (35.5%) were resistant to MTX chemotherapy, and 34 (12.8%) needed multi-agent chemotherapy. Clinicopathologic diagnosis of postmolar choriocarcinoma (OR = 17.18, 95% CI: 4.64-63.70, P < 0.001) and higher pretreatment human chorionic gonadotropin concentration on a logarithmic scale (log-hCG concentration) (OR = 18.11, 95% CI: 3.72-88.15, P < 0.001) were identified as independent risk factors associated with MTX resistance according to multivariable logistic regression. The decision tree model and regression model were developed to predict the risk of MTX resistance in GTN patients with a FIGO score of 0-4. Evaluation of model discrimination, calibration and net benefit revealed the superiority of the decision tree model, which comprised clinicopathologic diagnosis and pretreatment hCG concentration. The patients in the high- and medium-risk groups of the decision tree model had a higher probability of MTX resistance. This study represents the investigation into MTX resistance in GTN patients with a FIGO score of 0-4 and disclosed a remission rate of approximately 65% with MTX chemotherapy. Higher pretreatment hCG concentration and clinicopathologic diagnosis of postmolar choriocarcinoma were independent risk factors associated with resistance to MTX chemotherapy. The decision tree model demonstrated enhanced predictive capabilities regarding the risk of MTX resistance and can serve as a valuable tool to guide the clinical treatment decisions for GTN patients with a FIGO score of 0-4.

Lectin Galactoside-Binding Soluble 3 Binding Protein Mediates Methotrexate Resistance in Choriocarcinoma Cell Lines.

Establishment of methotrexate-resistant human choriocarcinoma cell line and its biological characteristics]

Risk Factors for Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasia Patients (FIGO Score 0-4)

Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma

Cdna Microarray Analysis of Gene Expression in Acquired Methotrexate-Resistant of Human Choriocarcinoma

LncRNA MEG3-210 Regulates Endometrial Stromal Cells Migration, Invasion and Apoptosis Through P38 MAPK and PKA/SERCA2 Signalling Via Interaction with Galectin-1 in Endometriosis.

Evaluation of transport mechanisms of methotrexate in human choriocarcinoma cell lines by LC-MS/MS

Identification of cell cycle dependent methotrexate resistance in placenta site trophoblastic tumors

Regulation Mechanism of Autophagy-Related Protein LC3 by C-Jun in Methotrexate Resistant Human Choriocarcinoma JEG-3 Cells

Effects of Genistein on Proliferation, Apoptosis and Invasiveness in Methotrexate-Resistant Human Choriocarcinoma JAR/MTX Cells and It's Mechanism

Methotrexate Induces Apoptosis of Human Choriocarcinoma Cell Line JAR Via a Mitochondrial Pathway.

Resistance and Its Mechanism of Methotrexate Against Malignant Lymphoma Cell Lines

Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell.

The m6A Methyltransferase METTL3 Promotes Cisplatin Resistance and Invasion in Testicular Seminoma via BCL2

Proteomic Identification Of Differentially Expressed Proteins Associated With The Multiple Drug Resistance In Methotrexate-Resistant Human Breast Cancer Cells

Dihydrofolate reductase transcript level is not suitable for methotrexate-resistance prediction in choriocarcinoma cell line

METTL3/LINC00662/miR-186-5p feedback loop regulates docetaxel resistance in triple negative breast cancer

Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line.

Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells

Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines

Resistance to methotrexate is associated with selective changes of alpha 2,6- and alpha 2,3-sialyltransferase activities toward N-acetyllactosaminic sequences in human colon cancer cell line HT-29.